News

BiO€QUITY Europe on 17-19 May 2021

Date
May 17, 2021
No items found.

MNM Diagnostics has developed a unique AI-powered platform allowing for the rapid development of genome-based biomarkers providing an accurate prediction of the treatment outcomes for cancer patients.

To date, we have developed and validated novel biomarker signatures for PARPi and CKD4/6i.

Feel free to request meeting to learn more about MNM Diagnostics during BiO€QUITY Europe conference on 17-19 May 2021

BiO€QUITY Europe on 17-19 May 2021
June 22, 2022

You may also like

Publication in Molecular Diagnosis & Therapy has been just released

MNM Biosciences, in co-operation with leading Polish cancer centers, has recently published a breakthrough publication concerning breast cancer diagnostics.

BiO€QUITY Europe on 17-19 May 2021

MNM Diagnostics has developed a unique AI-powered platform allowing for the rapid development of genome-based biomarkers providing an accurate prediction of the treatment outcomes for cancer patients.

Our latest Nature Immunology article has been just released

In the Perspective work-issued today, we highlight the possible genetic background of COVID-19 interindividual variability, ranging from asymptomatic infection to life-threatening disease.

Krzysztof Bokiej is a speaker at Data Science Summit ML Edition

Krzysztof Bokiej - Head of Platform and Pipelines at MNM - is a speaker at the most important Machine Learning conference in Poland.